Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Language
Publication year range
1.
Dev Cell ; 1(1): 13-25, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11703920

ABSTRACT

Recent studies have yielded a number of important insights into the mechanisms of hair follicle development and cycling and have highlighted the particularly important roles played by stem cells and Wnt signaling pathways.


Subject(s)
Hair Follicle/cytology , Hair Follicle/growth & development , Signal Transduction/physiology , Animals , Cell Division/physiology , Humans , Stem Cells/cytology
2.
Genes Dev ; 15(13): 1688-705, 2001 Jul 01.
Article in English | MEDLINE | ID: mdl-11445543

ABSTRACT

In skin, multipotent stem cells generate the keratinocytes of the epidermis, sebaceous gland, and hair follicles. In this paper, we show that Tcf3 and Lef1 control these differentiation lineages. In contrast to Lef1, which requires Wnt signaling and stabilized beta-catenin to express the hair-specific keratin genes and control hair differentiation, Tcf3 can act independently of its beta-catenin interacting domain to suppress features of epidermal terminal differentiation, in which Tcf3 is normally shut off, and promote features of the follicle outer root sheath (ORS) and multipotent stem cells (bulge), the compartments which naturally express Tcf3. These aspects of Tcf3's action are dependent on its DNA binding and Groucho repressor-binding domains. In the absence of its beta-catenin interacting domain, Lef1's behavior (Delta NLef1) seems to be markedly distinct from that of Delta NTcf3. Delta NLef1 does not suppress epidermal differentiation and promote ORS/bulge differentiation, but rather suppresses hair differentiation and gives rise to sebocyte differentiation. Taken together, these findings provide powerful evidence that the status of Tcf3/Lef complexes has a key role in controlling cell fate lineages in multipotent skin stem cells.


Subject(s)
DNA-Binding Proteins/metabolism , HMGB Proteins , Skin/cytology , Stem Cells/cytology , Trans-Activators , Transcription Factors/metabolism , Animals , Cell Differentiation , Cell Lineage , Cell Nucleus/metabolism , Cells, Cultured , Cytoskeletal Proteins/metabolism , DNA-Binding Proteins/genetics , Epidermal Cells , Epidermis/metabolism , Humans , Keratinocytes/cytology , Lymphoid Enhancer-Binding Factor 1 , Mice , Mice, Transgenic , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , TCF Transcription Factors , Transcription Factor 7-Like 1 Protein , Transcription Factors/genetics , beta Catenin
3.
Mol Cell Biol ; 19(11): 7801-15, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10523669

ABSTRACT

To understand the role of POL30 in mutation suppression, 11 Saccharomyces cerevisiae pol30 mutator mutants were characterized. These mutants were grouped based on their mutagenic defects. Many pol30 mutants harbor multiple mutagenic defects and were placed in more than one group. Group A mutations (pol30-52, -104, -108, and -126) caused defects in mismatch repair (MMR). These mutants exhibited mutation rates and spectra reminiscent of MMR-defective mutants and were defective in an in vivo MMR assay. The mutation rates of group A mutants were enhanced by a msh2 or a msh6 mutation, indicating that MMR deficiency is not the only mutagenic defect present. Group B mutants (pol30-45, -103, -105, -126, and -114) exhibited increased accumulation of either deletions alone or a combination of deletions and duplications (4 to 60 bp). All deletion and duplication breakpoints were flanked by 3 to 7 bp of imperfect direct repeats. Genetic analysis of one representative group B mutant, pol30-126, suggested polymerase slippage as the likely mutagenic mechanism. Group C mutants (pol30-100, -103, -105, -108, and -114) accumulated base substitutions and exhibited synergistic increases in mutation rate when combined with msh6 mutations, suggesting increased DNA polymerase misincorporation as a mutagenic defect. The synthetic lethality between a group A mutant, pol30-104, and rad52 was almost completely suppressed by the inactivation of MSH2. Moreover, pol30-104 caused a hyperrecombination phenotype that was partially suppressed by a msh2 mutation. These results suggest that pol30-104 strains accumulate DNA breaks in a MSH2-dependent manner.


Subject(s)
Amino Acid Transport Systems , Base Pair Mismatch , DNA Repair , DNA Replication , Fungal Proteins/genetics , Mutagenesis , Proliferating Cell Nuclear Antigen/genetics , Saccharomyces cerevisiae/genetics , Base Sequence , DNA-Directed DNA Polymerase/metabolism , Frameshift Mutation , Membrane Transport Proteins/genetics , Molecular Sequence Data , Mutagenesis, Insertional , Point Mutation , Sequence Deletion
4.
Genetics ; 153(2): 595-605, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10511542

ABSTRACT

To examine the role of the RAD52 recombinational repair pathway in compensating for DNA replication defects in Saccharomyces cerevisiae, we performed a genetic screen to identify mutants that require Rad52p for viability. We isolated 10 mec1 mutations that display synthetic lethality with rad52. These mutations (designated mec1-srf for synthetic lethality with rad-fifty-two) simultaneously cause two types of phenotypes: defects in the checkpoint function of Mec1p and defects in the essential function of Mec1p. Velocity sedimentation in alkaline sucrose gradients revealed that mec1-srf mutants accumulate small single-stranded DNA synthesis intermediates, suggesting that Mec1p is required for the normal progression of DNA synthesis. sml1 suppressor mutations suppress both the accumulation of DNA synthesis intermediates and the requirement for Rad52p in mec1-srf mutants, but they do not suppress the checkpoint defect in mec1-srf mutants. Thus, it appears to be the DNA replication defects in mec1-srf mutants that cause the requirement for Rad52p. By using hydroxyurea to introduce similar DNA replication defects, we found that single-stranded DNA breaks frequently lead to double-stranded DNA breaks that are not rapidly repaired in rad52 mutants. Taken together, these data suggest that the RAD52 recombinational repair pathway is required to prevent or repair double-stranded DNA breaks caused by defective DNA replication in mec1-srf mutants.


Subject(s)
DNA Repair/genetics , DNA Replication/genetics , Fungal Proteins/genetics , Recombination, Genetic , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , DNA, Fungal/biosynthesis , DNA, Fungal/genetics , DNA, Single-Stranded/biosynthesis , DNA, Single-Stranded/genetics , DNA-Binding Proteins/genetics , Fungal Proteins/metabolism , Genotype , Hydroxyurea/pharmacology , Intracellular Signaling Peptides and Proteins , Mutagenesis , Protein Serine-Threonine Kinases , Rad52 DNA Repair and Recombination Protein , Saccharomyces cerevisiae/drug effects
5.
Genetics ; 148(2): 611-24, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9504910

ABSTRACT

To identify in vivo pathways that compensate for impaired proliferating cell nuclear antigen (PCNA or Pol30p in yeast) activity, we performed a synthetic lethal screen with the yeast pol30-104 mutation. We identified nine mutations that display synthetic lethality with pol30-104; three mutations affected the structural gene for the large subunit of replication factor C (rfc1), which loads PCNA onto DNA, and six mutations affected three members of the RAD52 epistasis group for DNA recombinational repair (rad50, rad52 and rad57). We also found that pol30-104 displayed synthetic lethality with mutations in other members of the RAD52 epistasis group (rad51 and rad54), but not with mutations in members of the RAD3 nor the RAD6 epistasis group. Analysis of nine different pol30 mutations shows that the requirement for the RAD52 pathway is correlated with a DNA replication defect but not with the relative DNA repair defect caused by pol30 mutations. In addition, mutants that require RAD52 for viability (pol30-100, pol30-104, rfc1-1 and rth1delta) accumulate small single-stranded DNA fragments during DNA replication in vivo. Taken together, these data suggest that the RAD52 pathway is required when there are defects in the maturation of Okazaki fragments.


Subject(s)
DNA Repair/genetics , DNA-Binding Proteins/genetics , Genes, pol/genetics , Proliferating Cell Nuclear Antigen/physiology , Recombination, Genetic/genetics , Saccharomyces cerevisiae/genetics , Cell Division/genetics , Cell Survival/genetics , Centrifugation, Density Gradient , DNA/genetics , DNA Replication/genetics , Epistasis, Genetic , Flow Cytometry , Models, Molecular , Mutagenesis/genetics , Mutation , Proliferating Cell Nuclear Antigen/genetics , Rad52 DNA Repair and Recombination Protein , Saccharomyces cerevisiae Proteins , Temperature
7.
Arch Biochem Biophys ; 308(1): 133-6, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8311445

ABSTRACT

Neprilysin is a peptidase which has a specificity directed toward cleavage on the amino side of hydrophobic residues. In addition an active site arginine on the enzyme can interact with the C-terminal carboxylate of a substrate. The importance of the position of the hydrophobic residue relative to the C-terminus of the substrate has been investigated using a series of peptides containing one or two cleavage sites. With a hexapeptide series succ-(GLy)x-Phe-(Gly)y-OH, where x = 1 to 5 and y = 5 to 1 respectively, a approximately 25-fold increase in the specificity constant kcat/Km was observed when Phe was adjacent to the C-terminal Gly residue. With peptide-free acids containing two cleavable bonds (X and Y) of the type succ-Gly-X-Gly-Y-Gly-OH, cleavage was observed at the Y residue. However, when the two cleavable bonds were adjacent, succ-Gly-Gly-X-Y-Gly-OH, cleavage of a tripeptide was observed even when the residue in position X was one cleaved poorly when presented as the sole cleavage site. These results demonstrate a preference by the enzyme for the placement of a hydrophobic residue in the P'2 position.


Subject(s)
Neprilysin/metabolism , Oligopeptides/metabolism , Amino Acid Sequence , Animals , Bombesin/chemistry , Bombesin/metabolism , Glycine , Kidney/enzymology , Molecular Sequence Data , Neprilysin/isolation & purification , Oligopeptides/chemical synthesis , Phenylalanine , Rats , Spectrometry, Fluorescence , Substrate Specificity
8.
FEBS Lett ; 335(1): 65-8, 1993 Nov 29.
Article in English | MEDLINE | ID: mdl-7694875

ABSTRACT

Regulation of cholecystokinin (CCK) expression was studied in the human neuroepithelioma cell line SK-N-MCIXC. The cells were treated with the phosphodiesterase inhibitor isobutyl-methylxanthine and the tumor promoting phorbol ester, phorbol-12-myristate 13-acetate; activators of the cyclic AMP (cAMP) and protein kinase C (PKC) second messenger pathways, respectively. Levels of CCK mRNA were determined after 6, 12 and 24 hour drug treatments, with Northern blot analysis using human CCK cDNA hybridization probes. Activation of both cAMP and PKC second messenger pathways increased CCK mRNA levels in SK-N-MCIXC cells. These results indicate that the levels of CCK mRNA in SK-N-MCIXC cells are regulated by cAMP and PKC dependent mechanisms.


Subject(s)
Cholecystokinin/genetics , Gene Expression Regulation , Neuroectodermal Tumors, Primitive, Peripheral/metabolism , RNA, Messenger/metabolism , Second Messenger Systems , 1-Methyl-3-isobutylxanthine/pharmacology , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Cell Line , Cyclic AMP/metabolism , Dimethyl Sulfoxide/pharmacology , Humans , Kinetics , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Tetradecanoylphorbol Acetate/pharmacology
9.
Life Sci ; 51(26): 2097-106, 1992.
Article in English | MEDLINE | ID: mdl-1361957

ABSTRACT

A specific enzyme assay for aminopeptidase M (APM) activity on rat brain membranes has been developed through selective use of enzyme inhibitors. Amastatin was the most potent inhibitor (amastatin > actinonin > MDL73347 > bestatin) for purified porcine kidney APM, giving 98% inhibition at a 6 microM concentration, while actinonin, yielded only 57% inhibition at this concentration. Puromycin (10 microM) was used to inhibit puromycin-sensitive aminopeptidase activity in the rat brain membrane preparation. Puromycin (10 microM) had only a slight effect on the Km of porcine kidney APM, and had negligible effect on APM velocity at the high substrate concentration (2 mM) used in the APM assay. The assay produced a linear accumulation of product for increasing amount of rat brain membranes used, and for increasing incubation time. The Km of APM on rat brain membranes for L-Leucine-p-nitroanilide (0.383 mM) was similar to the Km of purified porcine kidney APM (0.558 mM). APM-activity, involved in the metabolism of several biologically important neuropeptides in different brain regions, can be specifically measured with this enzyme assay.


Subject(s)
Aminopeptidases/analysis , Cerebral Cortex/enzymology , Aminopeptidases/antagonists & inhibitors , Animals , CD13 Antigens , Enzyme Inhibitors/pharmacology , Kidney/enzymology , Kinetics , Male , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL